Erste Group Bank Has Positive Outlook of UNH FY2027 Earnings

Key Points

• Erste Group modestly raised its FY2027 EPS estimate for UnitedHealth to $19.88 (from $19.77), while the street consensus for the current full year remains at $29.54 per share.
• CMS finalized a larger‑than‑expected ~2.48% Medicare Advantage payment increase, triggering analyst price‑target upgrades and a 9.3% stock rally as investors price in a revenue tailwind.
• The April 21 Q1 report is a near‑term catalyst — analysts expect the CMS bump to be baked into models, but lingering medical‑cost pressures and Optum margin recovery risks could reverse recent gains.

UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Analysts at Erste Group Bank raised their FY2027 EPS estimates for UnitedHealth Group in a research report issued on Thursday, April 2nd. Erste Group Bank analyst H. Engel now expects that the healthcare conglomerate will post earnings of $19.88 per share for the year, up from their previous forecast of $19.77. The consensus estimate for UnitedHealth Group's current full-year earnings is $29.54 per share.

A number of other analysts also recently weighed in on UNH. Piper Sandler restated an "overweight" rating on shares of UnitedHealth Group in a research note on Tuesday, January 27th. Barclays decreased their price objective on shares of UnitedHealth Group from $391.00 to $327.00 and set an "overweight" rating on the stock in a report on Friday, January 30th. Weiss Ratings downgraded shares of UnitedHealth Group from a "hold (c-)" rating to a "sell (d+)" rating in a report on Monday, March 2nd. UBS Group decreased their target price on UnitedHealth Group from $430.00 to $410.00 and set a "buy" rating on the stock in a research report on Wednesday, January 28th. Finally, Royal Bank Of Canada decreased their target price on UnitedHealth Group from $408.00 to $361.00 and set an "outperform" rating on the stock in a research report on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $363.42.

UnitedHealth Group Stock Up 9.3%

UnitedHealth Group stock opened at $307.55 on Wednesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $606.36. The company has a market cap of $279.16 billion, a PE ratio of 23.32, a price-to-earnings-growth ratio of 1.28 and a beta of 0.40. The stock's 50 day moving average price is $282.12 and its 200 day moving average price is $319.04.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $113.73 billion for the quarter, compared to the consensus estimate of $113.38 billion. During the same quarter in the previous year, the firm earned $6.81 earnings per share. The business's quarterly revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group's payout ratio is 67.02%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares during the period. CMT Capital Markets Trading GmbH acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $340,000. Flow Traders U.S. LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $356,000. Finally, Jump Financial LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth approximately $377,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: CMS finalized a bigger-than-expected 2027 Medicare Advantage payment increase (~2.48%), delivering a direct revenue tailwind for UnitedHealthcare and prompting the sector rally. Trump administration finalizes better-than-feared Medicare Advantage payment rate
• Positive Sentiment: Analysts raised price targets and ratings after the CMS decision (examples: BofA, Sanford Bernstein, Raymond James), reinforcing upside expectations and supporting buying momentum. Sanford C. Bernstein raises UNH target
• Positive Sentiment: Short-term technical and sentiment lift: above‑average volume, upward earnings‑estimate revisions, and coverage pieces calling UNH a margin‑expansion story point to further upside potential ahead of earnings. UnitedHealth Soars 9.4%: Is Further Upside Left?
• Neutral Sentiment: Upcoming Q1 report (April 21) is a near-term catalyst — Street models now factor in the CMS bump, so beats/misses and management commentary on medical cost trends and guidance will drive next moves. Will UnitedHealth Group beat quarterly earnings?
• Negative Sentiment: Lingering concerns remain: UNH has faced softer recent results, elevated medical-cost pressures and prior guidance weakness — if cost trends re‑accelerate or Optum margin recovery disappoints, gains could reverse. 2 Reasons to Watch UNH and 1 to Stay Cautious

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.